Hyponatremia in a patient with scleroderma renal crisis: A potential role of activated renin-angiotensin system

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Fukasawa, Hirotaka ^a   Furuya, Ryuichi ^a   Ishigaki, Sayaka ^a   Kinoshita, Naoko ^a   Isobe, Shinsuke ^a   Fujigaki, Yoshihide ^b  

^a Iwata City Hospital   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyponatremia; Renin angiotensin system; Scleroderma renal crisis

Indexed keywords

ALISKIREN; ANGIOTENSIN; CANDESARTAN; CANDESARTAN HEXETIL; CREATININE; DNA DIRECTED RNA POLYMERASE III; ENALAPRIL MALEATE; SODIUM; VASOPRESSIN;

ADRENAL CORTEX INSUFFICIENCY; AGED; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; KIDNEY DYSFUNCTION; MALE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCLERODERMA; SCLERODERMA RENAL CRISIS; SODIUM BLOOD LEVEL; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA NITROGEN BLOOD LEVEL;

AGED; HUMANS; HYPONATREMIA; KIDNEY DISEASES; MALE; RENIN-ANGIOTENSIN SYSTEM; SCLERODERMA, SYSTEMIC;

EID: 84862730977     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-47     Document Type: Article

References (13)

1. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH, Steen VD, Osial TA, Tolchin SF, Medicine (Baltimore) 1983 62 335 352
2. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. Lopez-Ovejero JA, Saal SD, D'Angelo WA, Cheigh JS, Stenzel KH, Laragh JH, N Engl J Med 1979 300 1417 1419 10.1056/NEJM197906213002505 220537
3. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Anderson RJ, Chung HM, Kluge R, Schrier RW, Ann Intern Med 1985 102 164 168 3966753
4. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Izzedine H, Fardet L, Launay-Vacher V, Dorent R, Petitclerc T, Deray G, Clin Pharmacol Ther 2002 71 503 507 10.1067/mcp.2002.124520 12087354
5. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Wright JW, Harding JW, Brain Res Rev 1992 17 227 262 10.1016/0165-0173(92)90018-H 1361394
6. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D, J Mol Med (Berl) 2001 79 76 102 10.1007/s001090100210
7. Origin of the angiotensin II secreted by cells. Ganong WF, Proc Soc Exp Biol Med 1994 205 213 219 8171042
8. Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Pelisch N, Hosomi N, Ueno M, Masugata H, Murao K, Hitomi H, Nakano D, Kobori H, Nishiyama A, Kohno M, Hypertens Res 2010 33 161 164 10.1038/hr.2009.200 19942928
9. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC, Arch Intern Med 2009 169 1195 1202 10.1001/archinternmed.2009.175 19597068
10. Angiotensin, thirst, and sodium appetite. Fitzsimons JT, Physiol Rev 1998 78 583 686 9674690
11. Regulation of drinking and vasopressin secretion: role of organum vasculosum laminae terminalis. Thrasher TN, Keil LC, Am J Physiol 1987 253 108 R120 3605376
12. Distribution of angiotensin-converting enzyme activity in specific areas of the rat brain stem. Chevillard C, Saavedra JM, J Neurochem 1982 38 281 284 10.1111/j.1471-4159.1982.tb10883.x 6286881
13. Angiotensin-converting enzyme in subfornical organ mediates captopril-induced drinking. Thunhorst RL, Fitts DA, Simpson JB, Behav Neurosci 1989 103 1302 1310 2558676